Over the last 15 years, FOCUS has conducted more than 75 NCEs “First-into-Man” and over 600 Phase I to III studies, covering numerous therapeutic areas.

Upon request, we can offer you detailed information on concrete experiences in each of the therapeutic areas, as listed to the right.

FOCUS has tested a broad spectrum of compounds, ranging from standard low molecular weight compounds to large biologicals and proteins. We have performed studies in cooperation with numerous biotech companies with recombinant proteins (growth-hormone, renal peptide hormone, interferons, hepatitis vaccines), monoclonal-antibodies, RNA-fragments (Oligodeoxynucleotides) and tumor vaccines (cell therapy).

Our physicians are specialised in clinical pharmacology, CVS, CNS, diabetes, immunology, oncology, anesthesia, general and emergency medicine.

FOCUS has excellent connections to the local and international university hospitals and experienced clinical specialists.

 

Recent Case studies (last 18 month):